All Articles

The era of self-balancing motorcycles is here. OMOWAY's AI-powered OMO X enters mass production, promising to revolutionize rider safety and urban mobility.

With a new CEO and private equity backing, meQuilibrium is betting its AI platform can solve the billion-dollar burnout and mental health crisis.

At embedded world 2026, ThunderSoft showcased new edge AI solutions for robotics and industrial automation, signaling a major shift to on-device intelligence.

Kestrel Group reports soaring fee income from its core business, but a quarterly loss reveals the deep financial drag from its complex merger with Maiden Holdings.

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.

Advocates and doctors urge lowering the colorectal cancer screening age to 45 as rates soar in young adults, sparking a debate on policy and resources.

Institutional Investor launches an allocator-curated 'Buy List' to benchmark private equity excellence, prioritizing transparency and governance over marketing.

Rob Levine Law offers free Uber vouchers in Boston and Providence via its app, aiming to boost safety during St. Patrick's Day festivities.

Emerald Holding reports a 16% revenue jump but a $30.7M net loss, driven by acquisition costs, as the board considers a potential company sale.

Andreas Szakacs Productions unveils "Shadow Fist," an MMA drama built on a new financial model that could change how independent films get made.

At SXSW, Reckitt Catalyst and Serena Williams unveil a new cohort of U.S. entrepreneurs tackling America's deep-rooted healthcare access crisis.

As the Federal Reserve's hawkish signals roil precious metals, a new report urges disciplined strategies. But is platform education enough for investors?

With domestic production falling and global supplies at risk, experts warn a helium shortage could cripple key U.S. industries from defense to semiconductors.

The healthcare REIT's significant dividend increase is backed by a record year of investment, a strong balance sheet, and strategic expansion into new markets.

The engineering giant renews its massive share buyback plan, signaling deep confidence in its stock amid a nuclear boom and a unique pact with La Caisse.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

The organic gardening firm returns to its origins with a new soil amendment, bringing a professional farmer's secret to home gardens via The Home Depot.

Italian med-tech firm Esaote unveils its AI-driven Prostate Attention Map, promising a new era of accuracy and confidence in prostate cancer detection.

A landmark study reveals an accelerated brain stimulation protocol can treat major depression in six days, offering rapid relief and dismantling barriers to care.

A new integrated liquid cooling system aims to shatter the thermal barriers limiting AI performance, promising denser, more efficient data centers.